{"id":5663,"date":"2024-08-12T09:40:13","date_gmt":"2024-08-12T09:40:13","guid":{"rendered":"https:\/\/www.katheraugenstein.com\/?post_type=news&#038;p=5663"},"modified":"2024-08-12T11:17:36","modified_gmt":"2024-08-12T11:17:36","slug":"the-pharmaceutical-intellectual-property-and-competition-christopher-weber-and-dr-benjamin-pesch-publish-on-recent-developments-in-intellectual-property-and-competition-law-in-the-pharmaceutical-sec","status":"publish","type":"news","link":"https:\/\/www.katheraugenstein.com\/en\/news\/the-pharmaceutical-intellectual-property-and-competition-christopher-weber-and-dr-benjamin-pesch-publish-on-recent-developments-in-intellectual-property-and-competition-law-in-the-pharmaceutical-sec\/","title":{"rendered":"The Pharmaceutical Intellectual Property and Competition &#8211; Christopher Weber and Dr Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany"},"content":{"rendered":"\t<section class=\"section big-visual parallax\" data-parallax-min-screen-width=\"768\">\n\t\t<picture class=\"big-visual__image-container\"><source srcset=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/n-Depth-Pharmaceutical-Intellectual-Property-and-Competition-in-Germany-414x221.png\" width=\"414\" height=\"221\" media=\"(max-width: 414px)\" \/><source srcset=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/n-Depth-Pharmaceutical-Intellectual-Property-and-Competition-in-Germany-767x410.png\" width=\"767\" height=\"410\" media=\"(max-width: 767px)\" \/><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/n-Depth-Pharmaceutical-Intellectual-Property-and-Competition-in-Germany.png\" width=\"1920\" height=\"650\" alt=\"\" class=\"big-visual__image parallax__load-image\" loading=\"edge\" \/><\/picture>\n\t\t<div class=\"big-visual__content-container\">\n\t\t\t<div class=\"big-visual__content parallax__item\" data-parallax-type=\"move\" data-parallax-orientation=\"up\" data-parallax-distance=\"70%\">\n\t\t\t\t<p class=\"big-visual__title \">Latest <strong>News.<\/strong><\/p>\n\t\t\t\t<p class=\"big-visual__text\"><\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\n\n\t<section class=\"section text-box text-box--variant-1 \">\n\t\t\t\t\t<h2 class=\"h1\">\t\t\t\t\t<span class=\"subline\">The Pharmaceutical Intellectual Property and Competition &#8211; <\/span>\n\t\t\t\t\t\t\t\tChristopher Weber and Dr Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany<\/h2>\n\t\t\n\t\t<p class=\"text--intro\"><b><strong>The Pharmaceutical Intellectual Property and Competition,<\/strong><\/b> now in its 5th edition, rovides a practical overview of pharmaceutical intellectual property issues, including the nexus of patents, exclusivity rights and related competition issues.<\/p>\n<p class=\"text--intro\">With a focus on current developments, the guide serves as a valuable tool for managing global risks in this field &#8211; analysing key legal and regulatory aspects in major jurisdictions worldwide.<\/p>\n<p>Our team of authors, <b><strong>Christopher Weber<\/strong><\/b> and <b><strong>Dr Benjamin Pesch<\/strong><\/b>, have again written the <a href=\"https:\/\/www.lexology.com\/indepth\/pharmaceutical-intellectual-property-and-competition\/germany?utm_source=TLR&amp;utm_medium=pdf&amp;utm_campaign=Pharmaceutical+Intellectual+Property+and+Competition+-+Edition+5\">German chapter<\/a> in this year&#8217;s edition, which covers the principles and current developments of intellectual property and competition law in the German pharmaceutical sector.<\/p>\n<p><strong>&#8220;The Pharmaceutical Intellectual Property and Competition&#8221;<\/strong> is published this year on\u00a0<a href=\"https:\/\/www.lexology.com\/contributors\/kather-augenstein-rechtsanwalte-partgmbb\"> Lexology<\/a>, the exclusive platform for all <a href=\"https:\/\/www.lexology.com\/indepth\">The Law Reviews publications.<\/a><\/p>\n<p>Read the <a href=\"https:\/\/www.lexology.com\/indepth\/pharmaceutical-intellectual-property-and-competition\/editors-preface\">editor&#8217;s foreword<\/a> here.<\/p>\n<p><a href=\"https:\/\/www.katheraugenstein.com\/team\/christopher-weber\/\">Christoper Weber<\/a> and <a href=\"https:\/\/www.katheraugenstein.com\/team\/dr-benjamin-pesch\/\">Dr Benjamin Pesch<\/a> will be pleased to answer any detailed questions you may have.<\/p>\n\t\t\n\t\t\t<\/section>\n","protected":false},"template":"","class_list":["post-5663","news","type-news","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/news\/5663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/media?parent=5663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}